1
|
Jin L, Wang Q, Yan M, Gu J, Zhang K, Lam PKS, Ruan Y. Enantiospecific Uptake and Depuration Kinetics of Chiral Metoprolol and Venlafaxine in Marine Medaka ( Oryzias melastigma): Tissue Distribution and Metabolite Formation. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2023; 57:4471-4480. [PMID: 36877486 DOI: 10.1021/acs.est.2c08379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
Abstract
The increasing use of chiral pharmaceuticals has led to their widespread presence in the environment. However, their toxicokinetics have rarely been reported. Therefore, the tissue-specific uptake and depuration kinetics of two pairs of pharmaceutical enantiomers, S-(-)-metoprolol versus R-(+)-metoprolol and S-(+)-venlafaxine versus R-(-)-venlafaxine, were studied in marine medaka (Oryzias melastigma) during a 28-day exposure and 14-day clearance period. The toxicokinetics of the studied pharmaceuticals, including uptake and depuration rate constants, depuration half-life (t1/2), and bioconcentration factor (BCF), were reported for the first time. The whole-fish results demonstrated a higher S- than R-venlafaxine bioaccumulation potential, whereas no significant difference was observed between S- and R-metoprolol. O-desmethyl-metoprolol (ODM) and α-hydroxy-metoprolol (AHM) were the main metoprolol metabolites identified by suspect screening, and the ratios of ODM to AHM were 3.08 and 1.35 for S- and R-metoprolol, respectively. N,O-Didesmethyl-venlafaxine (NODDV) and N-desmethyl-venlafaxine (NDV) were the main venlafaxine metabolites, and the ratios of NODDV to NDV were 1.55 and 0.73 for S- and R-venlafaxine, respectively. The highest tissue-specific BCFs of the four enantiomers were all found in the eyes, meriting in-depth investigation.
Collapse
Affiliation(s)
- Linjie Jin
- State Key Laboratory of Marine Pollution (SKLMP), and Department of Chemistry, City University of Hong Kong, Kowloon 999077, Hong Kong SAR, China
| | - Qi Wang
- State Key Laboratory of Marine Pollution (SKLMP), and Department of Chemistry, City University of Hong Kong, Kowloon 999077, Hong Kong SAR, China
- Research Centre for the Oceans and Human Health, City University of Hong Kong Shenzhen Research Institute, Shenzhen 518057, China
| | - Meng Yan
- State Key Laboratory of Marine Pollution (SKLMP), and Department of Chemistry, City University of Hong Kong, Kowloon 999077, Hong Kong SAR, China
- Research Centre for the Oceans and Human Health, City University of Hong Kong Shenzhen Research Institute, Shenzhen 518057, China
- Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai 519000, China
| | - Jiarui Gu
- State Key Laboratory of Marine Pollution (SKLMP), and Department of Chemistry, City University of Hong Kong, Kowloon 999077, Hong Kong SAR, China
| | - Kai Zhang
- National Observation and Research Station of Coastal Ecological Environments in Macao, Macao Environmental Research Institute, Macau University of Science and Technology, Taipa 999078, Macao SAR, China
| | - Paul K S Lam
- Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai 519000, China
- Department of Science, School of Science and Technology, Hong Kong Metropolitan University, Kowloon 999077, Hong Kong SAR, China
| | - Yuefei Ruan
- State Key Laboratory of Marine Pollution (SKLMP), and Department of Chemistry, City University of Hong Kong, Kowloon 999077, Hong Kong SAR, China
- Research Centre for the Oceans and Human Health, City University of Hong Kong Shenzhen Research Institute, Shenzhen 518057, China
- Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai 519000, China
| |
Collapse
|
2
|
Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes. Arch Pharm Res 2022; 45:433-445. [PMID: 35763157 DOI: 10.1007/s12272-022-01394-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2022] [Accepted: 06/21/2022] [Indexed: 11/02/2022]
Abstract
Metoprolol, a selective β1-adrenoreceptor blocking agent used in the treatment of hypertension, angina, and heart failure, is primarily metabolized by the CYP2D6 enzyme, which catalyzes α-hydroxylation and O-desmethylation. As CYP2D6 is genetically highly polymorphic and the enzymatic activity differs greatly depending on the presence of the mutant allele(s), the pharmacokinetic profile of metoprolol is highly variable depending on the genotype of CYP2D6. The aim of study was to develop the physiologically based pharmacokinetic (PBPK) model of metoprolol related to CYP2D6 genetic polymorphism for personalized therapy with metoprolol. For PBPK modelling, our previous pharmacogenomic data were used. To obtain kinetic parameters (Km, Vmax, and CLint) of each genotype, the recombinant CYP enzyme of each genotype was incubated with metoprolol and metabolic rates were assayed. Based on these data, the PBPK model of metoprolol was developed and validated in different CYP2D6 genotypes using PK-Sim® software. As a result, the input values for various parameters for the PBPK model were presented and the PBPK model successfully described the pharmacokinetics of metoprolol in each genotype group. The simulated values were within the acceptance criterion (99.998% confidence intervals) compared with observed values. The PBPK model developed in this study can be used for personalized pharmacotherapy with metoprolol in individuals of various races, ages, and CYP2D6 genotypes.
Collapse
|
3
|
Rao PV, Rao AL, Maheswara Prasad SVU. Development and Validation of a Method for Simultaneous Estimation of Sitagliptin and Ertugliflozin in Rat Plasma by LC-MS method. CURR PHARM ANAL 2021. [DOI: 10.2174/1573412916999200630123120] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
The development of sound bioanalytical LC-MS (liquid chromatography-mass
spectroscopy) method(s) is of paramount importance during the process of drug discovery, development
and culminating in a marketing approval. The use of oral antidiabetic agents has been increased
significantly from the last decades and till now no bioanalytical method is available for quantitation of
sitagliptin (SG) and ertugliflozin (EG) in biological matrix which can be applied to pharmacokinetic
studies using LC-MS/MS.
Objective:
To develop a new, rapid and sensitive LC–MS/MS method for the simultaneous estimation of sitagliptin (SG)
and ertugliflozin (EG) in rat plasma by liquid–liquid extraction method (LLE) using deutereated sitagliptin (SGd6) and
ertugliflozin (EGd6).
Methods:
Chromatographic separation was carried out on a reverse phase Waters, Xetrra C18 (150mm x
4.6mm, 2μm) column using a mixture of acetonitrile and OPA buffer (50:50v/v) at a flow rate of
1ml/min in isocratic mode. Quantification was achieved using an electrospray ion interface operating in
positive mode, under Multiple Reaction Monitoring (MRM) conditions.
Results:
The method showed excellent linearity over the concentration range of 5.00- 75.00pg/mL for sitagliptin and 0.75-
11.35pg/mL ertugliflozin. The intra-batch and inter batch precision (%CV) was ≤ 4.3% and matrix effect (%CV) was
0.02% and 0.12% for sitagliptin at HQC and LQC, respectively. Matrix effect (%CV) was 0.08% and 0.33% for
ertugliflozin at HQC and LQC, respectively.
Conclusion:
The simplicity of the method allows for application in laboratories, presents a valuable tool for
pharmacokinetic studies. The particular assay has been proficiently put on pharmacokinetic study in rats subjects.
Collapse
Affiliation(s)
| | - Atmakuri Lakshmana Rao
- Vallabhaneni Venkatadri. Institute of Pharmaceutical Sciences, Gudlavalleru, A.P-521 356, India
| | | |
Collapse
|
4
|
Liu T, Li R, Zhang N, Cui Y, Zhao Y, Yu Z. Screening of differential components of Gegenqinlian decoction and their comparative pharmacokinetics in normal and pyrexia rats using UHPLC-FT-ICR-MS and UHPLC-MS/MS. Biomed Chromatogr 2021; 35:e5186. [PMID: 34075601 DOI: 10.1002/bmc.5186] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Revised: 05/26/2021] [Accepted: 05/28/2021] [Indexed: 11/11/2022]
Abstract
UHPLC combined with Fourier-transform ion cyclotron resonance MS metabonomic approach was employed to screen the differential components between normal rats and yeast-induced pyrexia rats after an oral administration of Gegenqinlian decoction (GQLD). Nine compounds, namely puerarin, daidzein, baicalin, wogonoside, wogonin, berberine, palmatine, jateorhizine, and coptisine, were identified as differential components in the plasma. A rapid, sensitive, selective, and accurate UHPLC-MS method was developed and fully validated for the simultaneous determination of the screened components in rat plasma after an oral administration of GQLD. The values for the limit of quantification ranged from 0.025 to 5.0 ng/mL. The inter- and intra-day precision of all analytes was ≤10.7%, with an accuracy of ≤10.5%. Good extraction recovery and matrix effects were also obtained. The method was successfully applied to a comparative pharmacokinetic study of GQLD in normal and pyrexia rats. The results showed that the pharmacokinetic behavior of the analytes was changed in pyrexia rats compared to normal rats. These results could provide beneficial guidance for clinical applications of GQLD.
Collapse
Affiliation(s)
- Ting Liu
- Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.,Department of Pharmacology, School of Pharmacy, Shenyang Medical College, Shenyang, China
| | - Ruiyun Li
- Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
| | - Nan Zhang
- Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
| | - Yue Cui
- Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
| | - Yunli Zhao
- Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
| | - Zhiguo Yu
- Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
| |
Collapse
|
5
|
Direct analysis in real time-mass spectrometry for rapid quantification of five anti-arrhythmic drugs in human serum: application to therapeutic drug monitoring. Sci Rep 2020; 10:15550. [PMID: 32968164 PMCID: PMC7511339 DOI: 10.1038/s41598-020-72490-w] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Accepted: 08/28/2020] [Indexed: 02/06/2023] Open
Abstract
Therapeutic drug monitoring (TDM) is necessary for the optimal administration of anti-arrhythmic drugs in the treatment of heart arrhythmia. The present study aimed to develop and validate a direct analysis in real time tandem mass spectrometry (DART–MS/MS) method for the rapid and simultaneous determination of five anti-arrhythmic drugs (metoprolol, diltiazem, amiodarone, propafenone, and verapamil) and one metabolite (5-hydroxy(OH)-propafenone) in human serum. After the addition of isotope-labeled internal standards and protein precipitation with acetonitrile, anti-arrhythmic drugs were ionized by DART in positive mode followed by multiple reaction monitoring (MRM) detection. The use of DART–MS/MS avoided the need for chromatographic separation and allowed rapid and ultrahigh throughput analysis of anti-arrhythmic drugs in a total run time of 30 s per sample. The DART–MS/MS method yielded satisfactory linearity (R2 ≥ 0.9906), accuracy (86.1–109.9%), and precision (≤ 14.3%) with minimal effect of biological matrixes. The method was successfully applied to analyzing 30 clinical TDM samples. The relative error (RE) of the concentrations obtained by DART–MS/MS and liquid chromatography-tandem mass spectrometry (LC–MS/MS) was within ± 13%. This work highlights the potential usefulness of DART for the rapid quantitative analysis of anti-arrhythmic drugs in human serum and gives rapid feedback in the clinical TDM practices.
Collapse
|
6
|
Thomas CD, Johnson JA. Pharmacogenetic factors affecting β-blocker metabolism and response. Expert Opin Drug Metab Toxicol 2020; 16:953-964. [PMID: 32726152 DOI: 10.1080/17425255.2020.1803279] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
INTRODUCTION β-blockers are among the most widely prescribed of all drugs, used for treatment of a large number of cardiovascular diseases. Herein we evaluate literature pertaining to pharmacogenetics of β-blocker therapy, provide insight into the robustness of the genetic associations, and determine the appropriateness for translating these genetic associations into clinical practice. AREAS COVERED A literature search was conducted using PubMed to collate evidence on associations between CYP2D6, ADRB1, ADRB2, and GRK5 genetic variation and drug-response outcomes in the presence of β-blocker exposure. Pharmacokinetic, pharmacodynamic, and clinical outcomes studies were included if genotype data and β-blocker exposure were documented. EXPERT OPINION Substantial data suggest that specific ADRB1 and GRK5 genotypes are associated with improved β-blocker efficacy and have potential for use to guide therapy decisions in the clinical setting. While the data do not justify ordering a CYP2D6 pharmacogenetic test, if CYP2D6 genotype is available in the electronic health record, there may be clinical utility for understanding dosing of β-blockers.
Collapse
Affiliation(s)
- Cameron D Thomas
- Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida , Gainesville, FL, USA
| | - Julie A Johnson
- Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida , Gainesville, FL, USA
| |
Collapse
|
7
|
Burkina V, Sakalli S, Giang PT, Grabicová K, Staňová AV, Zamaratskaia G, Zlabek V. In Vitro Metabolic Transformation of Pharmaceuticals by Hepatic S9 Fractions from Common Carp (Cyprinus carpio). Molecules 2020; 25:molecules25112690. [PMID: 32531944 PMCID: PMC7321103 DOI: 10.3390/molecules25112690] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Revised: 06/02/2020] [Accepted: 06/05/2020] [Indexed: 11/16/2022] Open
Abstract
Water from wastewater treatment plants contains concentrations of pharmaceutically active compounds as high as micrograms per liter, which can adversely affect fish health and behavior, and contaminate the food chain. Here, we tested the ability of the common carp hepatic S9 fraction to produce the main metabolites from citalopram, metoprolol, sertraline, and venlafaxine. Metabolism in fish S9 fractions was compared to that in sheep. The metabolism of citalopram was further studied in fish. Our results suggest a large difference in the rate of metabolites formation between fish and sheep. Fish hepatic S9 fractions do not show an ability to form metabolites from venlafaxine, which was also the case for sheep. Citalopram, metoprolol, and sertraline were metabolized by both fish and sheep S9. Citalopram showed concentration-dependent N-desmethylcitalopram formation with Vmax = 1781 pmol/min/mg and Km = 29.7 μM. The presence of ellipticine, a specific CYP1A inhibitor, in the incubations reduced the formation of N-desmethylcitalopram by 30-100% depending on the applied concentration. These findings suggest that CYP1A is the major enzyme contributing to the formation of N-desmethylcitalopram. In summary, the results from the present in vitro study suggest that common carp can form the major metabolites of citalopram, metoprolol, and sertraline.
Collapse
Affiliation(s)
- Viktoriia Burkina
- South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Faculty of Fisheries and Protection of Waters, University of South Bohemia in Ceske Budejovice, Zatisi 728/II, 389 25 Vodňany, Czech Republic; (S.S.); (P.T.G.); (K.G.); (A.V.S.); (G.Z.); (V.Z.)
- Department of Molecular Sciences, Swedish University of Agricultural Sciences, P.O. Box 7015, SE-750 07 Uppsala, Sweden
- Correspondence: ; Tel.: +420-777318672; Fax: +420-387774634
| | - Sidika Sakalli
- South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Faculty of Fisheries and Protection of Waters, University of South Bohemia in Ceske Budejovice, Zatisi 728/II, 389 25 Vodňany, Czech Republic; (S.S.); (P.T.G.); (K.G.); (A.V.S.); (G.Z.); (V.Z.)
| | - Pham Thai Giang
- South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Faculty of Fisheries and Protection of Waters, University of South Bohemia in Ceske Budejovice, Zatisi 728/II, 389 25 Vodňany, Czech Republic; (S.S.); (P.T.G.); (K.G.); (A.V.S.); (G.Z.); (V.Z.)
- Research Institute for Aquaculture No 1, Dinh Bang 220000, Tu Son, Bac Ninh, Vietnam
| | - Kateřina Grabicová
- South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Faculty of Fisheries and Protection of Waters, University of South Bohemia in Ceske Budejovice, Zatisi 728/II, 389 25 Vodňany, Czech Republic; (S.S.); (P.T.G.); (K.G.); (A.V.S.); (G.Z.); (V.Z.)
| | - Andrea Vojs Staňová
- South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Faculty of Fisheries and Protection of Waters, University of South Bohemia in Ceske Budejovice, Zatisi 728/II, 389 25 Vodňany, Czech Republic; (S.S.); (P.T.G.); (K.G.); (A.V.S.); (G.Z.); (V.Z.)
- Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovicova 6, SK-842 15 Bratislava, Slovakia
| | - Galia Zamaratskaia
- South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Faculty of Fisheries and Protection of Waters, University of South Bohemia in Ceske Budejovice, Zatisi 728/II, 389 25 Vodňany, Czech Republic; (S.S.); (P.T.G.); (K.G.); (A.V.S.); (G.Z.); (V.Z.)
- Department of Molecular Sciences, Swedish University of Agricultural Sciences, P.O. Box 7015, SE-750 07 Uppsala, Sweden
| | - Vladimir Zlabek
- South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Faculty of Fisheries and Protection of Waters, University of South Bohemia in Ceske Budejovice, Zatisi 728/II, 389 25 Vodňany, Czech Republic; (S.S.); (P.T.G.); (K.G.); (A.V.S.); (G.Z.); (V.Z.)
| |
Collapse
|
8
|
Brocker CN, Velenosi T, Flaten HK, McWilliams G, McDaniel K, Shelton SK, Saben J, Krausz KW, Gonzalez FJ, Monte AA. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. Hum Genomics 2020; 14:10. [PMID: 32160915 PMCID: PMC7066769 DOI: 10.1186/s40246-020-00260-w] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Accepted: 02/28/2020] [Indexed: 11/17/2022] Open
Abstract
Introduction Metoprolol succinate is a long-acting beta-blocker prescribed for the management of hypertension (HTN) and other cardiovascular diseases. Metabolomics, the study of end-stage metabolites of upstream biologic processes, yield insight into mechanisms of drug effectiveness and safety. Our aim was to determine metabolomic profiles associated with metoprolol effectiveness for the treatment of hypertension. Methods We performed a prospective pragmatic trial (NCT02293096) that enrolled patients between 30 and 80 years with uncontrolled HTN. Patients were started on metoprolol succinate at a dose based upon systolic blood pressure (SBP). Urine and blood pressure measurements were collected weekly. Individuals with a 10% decline in SBP or heart rate (HR) were considered responsive. Genotype for the CYP2D6 enzyme, the primary metabolic pathway for metoprolol, was evaluated for each subject. Unbiased metabolomic analyses were performed on urine samples using UPLC-QTOF mass spectrometry. Results Urinary metoprolol metabolite ratios are indicative of patient CYP2D6 genotypes. Patients taking metoprolol had significantly higher urinary levels of many gut microbiota-dependent metabolites including hydroxyhippuric acid, hippuric acid, and methyluric acid. Urinary metoprolol metabolite profiles of normal metabolizer (NM) patients more closely correlate to ultra-rapid metabolizer (UM) patients than NM patients. Metabolites did not predict either 10% SBP or HR decline. Conclusion In summary, urinary metabolites predict CYP2D6 genotype in hypertensive patients taking metoprolol. Metoprolol succinate therapy affects the microbiome-derived metabolites.
Collapse
Affiliation(s)
- Chad N Brocker
- Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| | - Thomas Velenosi
- Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| | - Hania K Flaten
- Department of Emergency Medicine & Colorado Center for Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA
| | - Glenn McWilliams
- Department of Emergency Medicine & Colorado Center for Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA
| | - Kyle McDaniel
- Department of Emergency Medicine & Colorado Center for Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA
| | - Shelby K Shelton
- Department of Emergency Medicine & Colorado Center for Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA
| | - Jessica Saben
- Department of Emergency Medicine & Colorado Center for Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA
| | - Kristopher W Krausz
- Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| | - Frank J Gonzalez
- Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| | - Andrew A Monte
- Department of Emergency Medicine & Colorado Center for Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA. .,Rocky Mountain Poison & Drug Center, Denver Health and Hospital Authority, Denver, CO, USA. .,Department of Pharmaceutical Sciences, University of Colorado School of Pharmacy, 12401 E 17th Ave, Aurora, CO, 80045, USA.
| |
Collapse
|
9
|
Cusinato DAC, Filgueira GCDO, Rocha A, Cintra MAC, Lanchote VL, Coelho EB. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses. J Pharm Biomed Anal 2019; 164:430-441. [DOI: 10.1016/j.jpba.2018.10.029] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2018] [Revised: 09/14/2018] [Accepted: 10/17/2018] [Indexed: 11/29/2022]
|
10
|
Ultrasound assisted dispersive liquid-liquid microextraction coupled with high performance liquid chromatography designated for bioavailability studies of felodipine combinations in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2017; 1046:200-210. [DOI: 10.1016/j.jchromb.2017.01.034] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2016] [Revised: 12/30/2016] [Accepted: 01/21/2017] [Indexed: 10/20/2022]
|
11
|
Song Y, Wang Z, Feng X, Deng X, Zhu J. Simultaneous determination and pharmacokinetics of four triterpenoids by ultra high performance liquid chromatography with tandem mass spectrometry after the oral administration of Acanthopanax sessiliflorus (Rupr. et Maxim) Seem extract. J Sep Sci 2016; 39:2229-37. [PMID: 27324351 DOI: 10.1002/jssc.201501350] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2015] [Revised: 03/31/2016] [Accepted: 04/02/2016] [Indexed: 11/09/2022]
Abstract
A specific, simple, and sensitive ultra high performance liquid chromatography with tandem mass spectrometry method utilizing the Triple Quad system has been developed and validated for the simultaneous determination and pharmacokinetic study of four triterpenoid components of Acanthopanax sessiliflorus in rat plasma. The components are 22-α-hydroxychiisanogenin, chiisanogenin, (1R,11α)1,4-epoxy-11-hrdroxy-3,4-secolupane-20(30)-ene-3,28-dioic acid, and 22-α-hydroxychiisanoside. Sample preparation involved a liquid-liquid extraction of the analytes with ethyl acetate. Chromatographic separation was accomplished using an Agilent SB-C18 column (1.8 μm, 2.1 mm × 50 mm) with 2.0 min isocratic elution. The compounds were detected with a triple quadrupole tandem mass spectrometer in multiple reaction monitoring mode and an ESI source in negative mode. The method was linear for all analytes over the investigated range, with all determined correlation coefficients exceeding 0.9906. The limit of quantification of each analyte was lower than 1 ng/mL. The intraday and interday precisions were less than 14.9%, and the accuracy ranged from -10.2 to 11.8%. The mean recoveries of the analytes were higher than 80.0%, and the matrix effects were between 100.4 and 107.1%. These results may contribute to determining the mechanism of action and guiding the clinical application of Acanthopanax sessiliflorus.
Collapse
Affiliation(s)
- Yang Song
- School of Pharmacy, China Medical University, Shenyang, China
| | - Zhibin Wang
- Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin, China
| | - Xuesong Feng
- School of Pharmacy, China Medical University, Shenyang, China
| | - Xiaolan Deng
- School of Pharmacy, China Medical University, Shenyang, China
| | - Juan Zhu
- School of Pharmacy, China Medical University, Shenyang, China
| |
Collapse
|
12
|
Gan C, Liu L, Du Y, Wang L, Gao M, Wu L, Yang C. Simultaneous determination and pharmacokinetic study of four phenol compounds in rat plasma by ultra-high performance liquid chromatography with tandem mass spectrometry after oral administration of Echinacea purpurea
extract. J Sep Sci 2016; 39:1628-37. [DOI: 10.1002/jssc.201600051] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2016] [Revised: 02/11/2016] [Accepted: 02/21/2016] [Indexed: 12/28/2022]
Affiliation(s)
- Chunli Gan
- College of Pharmacy; Harbin Medical University; Nangang District Harbin China
| | - Lu Liu
- College of Pharmacy; Harbin Medical University; Nangang District Harbin China
| | - Yan Du
- College of Pharmacy; Harbin Medical University; Nangang District Harbin China
| | - Liqian Wang
- College of Pharmacy; Harbin Medical University; Nangang District Harbin China
| | - Mingjie Gao
- College of Pharmacy; Harbin Medical University; Nangang District Harbin China
| | - Lijun Wu
- College of Pharmacy; Harbin Medical University; Nangang District Harbin China
| | - Chunjuan Yang
- College of Pharmacy; Harbin Medical University; Nangang District Harbin China
| |
Collapse
|
13
|
Elmongy H, Ahmed H, Wahbi AA, Amini A, Colmsjö A, Abdel-Rehim M. Determination of metoprolol enantiomers in human plasma and saliva samples utilizing microextraction by packed sorbent and liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2016; 30:1309-17. [DOI: 10.1002/bmc.3685] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2015] [Revised: 01/04/2016] [Accepted: 01/08/2016] [Indexed: 11/11/2022]
Affiliation(s)
- Hatem Elmongy
- Department of Environmental Science and Analytical Chemistry; Stockholm University; SE10691 Stockholm Sweden
- Pharmaceutical Analysis Department, Faculty of Pharmacy; Damanhour University; Damanhour 22511 Egypt
| | - Hytham Ahmed
- Pharmaceutical Analysis Department, Faculty of Pharmacy; Damanhour University; Damanhour 22511 Egypt
| | - Abdel-Aziz Wahbi
- Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy; University of Alexandria; Alexandria 21521 Egypt
| | | | - Anders Colmsjö
- Department of Environmental Science and Analytical Chemistry; Stockholm University; SE10691 Stockholm Sweden
| | - Mohamed Abdel-Rehim
- Department of Environmental Science and Analytical Chemistry; Stockholm University; SE10691 Stockholm Sweden
| |
Collapse
|
14
|
Ma YR, Rao Z, Shi AX, Wang YF, Huang J, Han M, Wang XD, Jin YW, Zhang GQ, Zhou Y, Zhang F, Qin HY, Wu XA. Simultaneous Determination of Metformin, Metoprolol and its Metabolites in Rat Plasma by LC–MS-MS: Application to Pharmacokinetic Interaction Study. J Chromatogr Sci 2015; 54:1-9. [DOI: 10.1093/chromsci/bmv097] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2014] [Indexed: 11/15/2022]
|
15
|
Ford KA, Ryslik G, Sodhi J, Halladay J, Diaz D, Dambach D, Masuda M. Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications. Drug Metab Rev 2015; 47:291-319. [DOI: 10.3109/03602532.2015.1047026] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
16
|
Choi WK, Yoon KD, Lee JK, Park JB, Heo TH, Lee C, Bae SK. Development and validation of a liquid chromatography with tandem mass spectrometry method for the quantification of vitisin B in rat plasma and urine. J Sep Sci 2015; 38:1872-80. [PMID: 25808507 DOI: 10.1002/jssc.201500071] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2015] [Revised: 03/02/2015] [Accepted: 03/11/2015] [Indexed: 11/12/2022]
Abstract
A new, rapid, and sensitive liquid chromatography with tandem mass spectrometry method was developed for the determination of vitisin B and validated in rat plasma and urine using carbamazepine as an internal standard. The plasma (0.05 mL) or urine (0.2 mL) samples were extracted by liquid-liquid extraction with ethyl acetate and separated on an Eclipse Plus C18 column (100 × 4.6 mm, 3.5 μm) with a mobile phase consisting of acetonitrile and 0.1% formic acid water (60:40, v/v) at a flow rate of 0.7 mL/min. Detection and quantification were performed by mass spectrometry in selected reaction-monitoring mode with positive electrospray ionization. The calibration curves were recovered over the concentration ranges of 10-5000 ng/mL (correlation coefficients, r≥0.9833) in plasma and 5-2500 ng/mL (r≥0.9977) in urine, respectively. All validation data, including the specificity, precision, accuracy, recovery, and stability, conformed to the acceptance requirements. No matrix effects were observed. The developed method was successfully applied to pharmacokinetic studies of vitisin B following intravenous administration of 0.5 and 1 mg/kg and intraperitoneal injection of 5, 10, and 25 mg/kg to rats. This is the first report on the pharmacokinetic properties of vitisin B. The results provide a meaningful basis to evaluate preclinical or clinical applications of vitisin B.
Collapse
Affiliation(s)
- Woong-Kee Choi
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea
| | - Kee Dong Yoon
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea
| | - Joeng Kee Lee
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea
| | - Jung Bae Park
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea
| | - Tae-Hwe Heo
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea
| | - Choongho Lee
- College of Pharmacy, Dongguk University, Goyang, South Korea
| | - Soo Kyung Bae
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea
| |
Collapse
|
17
|
Rao Z, Ma YR, Qin HY, Wang YF, Wei YH, Zhou Y, Zhang GQ, Wang XD, Wu XA. Development of a LC-MS/MS method for simultaneous determination of metoprolol and its metabolites, α-hydroxymetoprolol and O-desmethylmetoprolol, in rat plasma: application to the herb-drug interaction study of metoprolol and breviscapine. Biomed Chromatogr 2015; 29:1453-60. [PMID: 25753317 DOI: 10.1002/bmc.3445] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2014] [Revised: 01/06/2015] [Accepted: 01/15/2015] [Indexed: 11/07/2022]
Abstract
A simple, specific and sensitive LC-MS/MS method was developed and validated for the simultaneous determination of metoprolol (MET), α-hydroxymetoprolol (HMT) and O-desmethylmetoprolol (DMT) in rat plasma. The plasma samples were prepared by protein precipitation, then the separation of the analytes was performed on an Agilent HC-C18 column (4.6 × 250 mm, 5 µm) at a flow rate of 1.0 mL/min, and post-column splitting (1:4) was used to give optimal interface flow rates (0.2 mL/min) for MS detection; the total run time was 8.5 min. Mass spectrometric detection was achieved using a triple-quadrupole mass spectrometer equipped with an electrospray source interface in positive ionization mode. The method was fully validated in terms of selectivity, linearity, accuracy, precision, stability, matrix effect and recovery over a concentration range of 3.42-7000 ng/mL for MET, 2.05-4200 ng/mL for HMT and 1.95-4000 ng/mL for DMT. The analytical method was successfully applied to herb-drug interaction study of MET and breviscapine after administration of breviscapine (12.5 mg/kg) and MET (40 mg/kg). The results suggested that breviscapine have negligible effect on pharmacokinetics of MET in rats; the information may be beneficial for the application of breviscapine in combination with MET in clinical therapy.
Collapse
Affiliation(s)
- Zhi Rao
- Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou, 730000, China
| | - Yan-rong Ma
- Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou, 730000, China.,School of Pharmacy, Lanzhou University, Lanzhou, 730000, China
| | - Hong-yan Qin
- Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou, 730000, China
| | - Ya-feng Wang
- Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou, 730000, China.,School of Pharmacy, Lanzhou University, Lanzhou, 730000, China.,Department of Pharmacy, Qinhai Provincial Hospital, Xining, 810007, China
| | - Yu-hui Wei
- Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou, 730000, China
| | - Yan Zhou
- Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou, 730000, China
| | - Guo-qiang Zhang
- Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou, 730000, China
| | - Xing-dong Wang
- Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou, 730000, China.,School of Pharmacy, Lanzhou University, Lanzhou, 730000, China
| | - Xin-an Wu
- Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou, 730000, China
| |
Collapse
|
18
|
Park JB, Bae SK, Bae SH, Oh E. Simultaneous determination of sarpogrelate and its active metabolite in human plasma by liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetic study. J Sep Sci 2014; 38:42-9. [DOI: 10.1002/jssc.201400884] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2014] [Revised: 10/08/2014] [Accepted: 10/16/2014] [Indexed: 11/09/2022]
Affiliation(s)
- Jung Bae Park
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences; The Catholic University of Korea; Bucheon Republic of Korea
| | - Soo Kyung Bae
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences; The Catholic University of Korea; Bucheon Republic of Korea
| | - Soo Hyeon Bae
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences; The Catholic University of Korea; Bucheon Republic of Korea
| | - Euichaul Oh
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences; The Catholic University of Korea; Bucheon Republic of Korea
| |
Collapse
|
19
|
Cho DY, Bae SH, Lee JK, Park JB, Kim YW, Lee S, Oh E, Kim BT, Bae SK. Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers. Xenobiotica 2014; 45:256-63. [PMID: 25268386 DOI: 10.3109/00498254.2014.967824] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
1. Recently, we demonstrated that sarpogrelate is a potent and selective CYP2D6 inhibitor in vitro. Here, we evaluated the effect of sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy subjects. 2. Nine healthy male subjects genotyped for CYP2D6*1/*1 or *1/*2 were included in an open-label, randomized, three treatment-period and crossover study. A single oral dose of metoprolol (100 mg) was administered with water (treatment A) and sarpogrelate (100 mg bid.; a total dose of 200 mg and treatment B), or after pretreatment of sarpogrelate for three days (100 mg tid.; treatment C). Plasma levels of metoprolol and α-hydroxymetoprolol were determined using a validated LC-MS/MS method. Changes in heart rate and blood pressure were monitored as pharmacodynamic responses to metoprolol. 3. Metoprolol was well tolerated in the three treatment groups. In treatment B and C groups, the AUCt of metoprolol increased by 53% (GMR, 1.53; 90% CI, 1.17-2.31) and by 51% (1.51; 1.17-2.31), respectively. Similar patterns were observed for the increase in Cmax of metoprolol by sarpogrelate. However, the pharmacodynamics of metoprolol did not differ significantly among the three treatment groups. 4. Greater systemic exposure to metoprolol after co-administration or pretreatment with sarpogrelate did not result in clinically relevant effects. Co-administration of both agents is well tolerated and can be employed without the need for dose adjustments.
Collapse
Affiliation(s)
- Doo-Yeoun Cho
- Department of Family Practice and Community Health, Ajou University School of Medicine , Yeongtong-gu, Suwon , South Korea
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Yoo H, Ryu KH, Bae SK, Kim J. Simultaneous determination of trifolirhizin, (-)-maackiain, (-)-sophoranone, and 2-(2,4-dihydroxyphenyl)-5,6-methylenedioxybenzofuran from Sophora tonkinensis in rat plasma by liquid chromatography with tandem mass spectrometry and its application to a ph. J Sep Sci 2014; 37:3235-44. [DOI: 10.1002/jssc.201400691] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2014] [Revised: 08/06/2014] [Accepted: 08/11/2014] [Indexed: 12/28/2022]
Affiliation(s)
- Hunseung Yoo
- College of Pharmacy and Research Institute of Pharmaceutical Sciences; Seoul National University; Seoul Korea
| | - Keun Ho Ryu
- New Drug Preclinical and Analytical Team; Life Science R&D Center, SK Chemicals; Pangyo-ro Korea
| | - Soo Kyung Bae
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences; The Catholic University of Korea; Bucheon Korea
| | - Jinwoong Kim
- College of Pharmacy and Research Institute of Pharmaceutical Sciences; Seoul National University; Seoul Korea
| |
Collapse
|
21
|
Magiera S, Baranowska I. A new and fast strategy based on semiautomatic microextraction by packed sorbent followed by ultra high performance liquid chromatography for the analysis of drugs and their metabolites in human urine. J Sep Sci 2014; 37:3314-5. [DOI: 10.1002/jssc.201400599] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2014] [Revised: 08/10/2014] [Accepted: 08/20/2014] [Indexed: 11/10/2022]
Affiliation(s)
- Sylwia Magiera
- Department of Inorganic; Analytical Chemistry and Electrochemistry; Silesian University of Technology; Gliwice Poland
| | - Irena Baranowska
- Department of Inorganic; Analytical Chemistry and Electrochemistry; Silesian University of Technology; Gliwice Poland
| |
Collapse
|
22
|
Musijowski J, Piórkowska E, Rudzki PJ. Determination of sunitinib in human plasma using liquid chromatography coupled with mass spectrometry. J Sep Sci 2014; 37:2652-8. [DOI: 10.1002/jssc.201400231] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2014] [Revised: 06/20/2014] [Accepted: 07/01/2014] [Indexed: 11/10/2022]
Affiliation(s)
- Jacek Musijowski
- Pharmacology Department, Pharmaceutical Research Institute; Warsaw Poland
| | - Edyta Piórkowska
- Pharmacology Department, Pharmaceutical Research Institute; Warsaw Poland
| | - Piotr J. Rudzki
- Pharmacology Department, Pharmaceutical Research Institute; Warsaw Poland
| |
Collapse
|